Grant: Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
McGill University
$4,800.00
Multi-System Neuroimaging Studies of Co-Morbid Addiction & Mental Illness
FY 2008-09
Summary
The primary objective is to create a new research team that
unites (i) the Department of Psychiatry / Montreal Neurological
Institute neuroimaging group, and (ii) the MUHC¿s Addictions
Unit specializing in the treatment of complex, co-morbid mental
illness and addiction. This new team will develop a novel
research program focused on combined volumetric, connectivity,
and multi-tracer PET studies of patients with co-morbid
substance use and other neuropsychiatric illnesses. In brief,
disturbances to motor and limbic cortico-striatal-thalamic-
cortical circuits are thought to increase susceptibility to
developing and expressing a wide range of mood, anxiety,
impulse-control and substance use disorders. Within these
pathways, the key neurotransmitters include dopamine (DA),
glutamate (Glu), gamma-aminobutyric acid (GABA), endogenous
opioids and serotonin (5-HT). Different combinations of
perturbations might predispose individuals to distinct clusters of
co-morbid conditions. By exploiting the development of the new
imaging methods and evaluating patients both before and after
treatment, we expect to obtain an unprecedented
characterization of addiction and its diverse co-morbidities; i.e.,
a detailed multi-system mapping of the relevant neurochemistry
and neurocircuitry in health, disease and recovery.
Department
Program
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
175916
Name
Leyton Marco
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Emerging Team Grant: Co-morbidity of brain disorders and other health problems
Projecttitle
Multi-System Neuroimaging Studies of Co-Morbid Addiction & Mental Illness
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$4,800
Cihrequipment2
$0
Programname2
Emerging Team Grant: Co-morbidity of brain disorders & other health problems-LOI
Keyworddelim
Co-Morbid Mental Illness; Depression; Magnetic Resonance Imaging; Personality Disorders; Positron Emission Tomograph; Substance Dependence
Abstract
The primary objective is to create a new research team that
unites (i) the Department of Psychiatry / Montreal Neurological
Institute neuroimaging group, and (ii) the MUHC¿s Addictions
Unit specializing in the treatment of complex, co-morbid mental
illness and addiction. This new team will develop a novel
research program focused on combined volumetric, connectivity,
and multi-tracer PET studies of patients with co-morbid
substance use and other neuropsychiatric illnesses. In brief,
disturbances to motor and limbic cortico-striatal-thalamic-
cortical circuits are thought to increase susceptibility to
developing and expressing a wide range of mood, anxiety,
impulse-control and substance use disorders. Within these
pathways, the key neurotransmitters include dopamine (DA),
glutamate (Glu), gamma-aminobutyric acid (GABA), endogenous
opioids and serotonin (5-HT). Different combinations of
perturbations might predispose individuals to distinct clusters of
co-morbid conditions. By exploiting the development of the new
imaging methods and evaluating patients both before and after
treatment, we expect to obtain an unprecedented
characterization of addiction and its diverse co-morbidities; i.e.,
a detailed multi-system mapping of the relevant neurochemistry
and neurocircuitry in health, disease and recovery.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Leyton, Marco; Gill, Kathryn J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $4,800~ $0~